Dubai-headquartered Kelix Bio, wholly owned by Abu Dhabi’s Mubadala Investment (Mubadala), has completed the acquisition of insulin manufacturer DiabTec, a subsidiary of Ras Al Khaimah-headquartered Julphar, for an undisclosed fee.
¬ Haymarket Media Limited. All rights reserved.
$(document).ready(function () {
googletag.cmd.push(function () {
googletag.defineSlot(‘/5450/new-financeasia/sidebar/sidebar-content’, [[300, 250], [300, 600]], ‘gpt-ad-sidebar-1cda787d85904034b2c449fe4c50ffd6’).addService(googletag.pubads());
googletag.pubads().enableSingleRequest();
googletag.pubads().collapseEmptyDivs(true);
googletag.enableServices();
});
$(‘#js-ad-1cda787d85904034b2c449fe4c50ffd6’).append(“
“);
googletag.cmd.push(function () {
googletag.display(‘gpt-ad-sidebar-1cda787d85904034b2c449fe4c50ffd6’);
});
googletag.cmd.push(function () {
googletag.pubads().addEventListener(‘slotRenderEnded’, function (event) {
if (event.slot.getSlotElementId().indexOf(‘gpt-ad-prestitial’)!==-1) {
if (!event.isEmpty) {
console.log(“presad”)
if (navigator.cookieEnabled)
window.prestAd.initCookie(10)
else if (window.localStorage) {
window.prestAd.initLocalStorage(10)
} else
console.log(‘no cookie & localstorage’);
}
}
});
});
});
Source : https://www.financeasia.com/article/mubadala-backed-kelix-bio-seals-mena-insulin-manufacturing-deal/500305
